Skip to main content
Erschienen in: Intensive Care Medicine 3/2009

01.03.2009 | Original

RETRACTED ARTICLE: The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients

verfasst von: Joachim Boldt, Stephan Suttner, Christian Brosch, Andreas Lehmann, Kerstin Röhm, Andinet Mengistu

Erschienen in: Intensive Care Medicine | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A balanced fluid replacement strategy appears to be promising for correcting hypovolemia. The benefits of a balanced fluid replacement regimen were studied in elderly cardiac surgery patients.

Methods

In a randomized clinical trial, 50 patients aged >75 years undergoing cardiac surgery received a balanced 6% HES 130/0.42 plus a balanced crystalloid solution (n = 25) or a non-balanced HES in saline plus saline solution (n = 25) to keep pulmonary capillary wedge pressure/central venous pressure between 12–14 mmHg. Acid-base status, inflammation, endothelial activation (soluble intercellular adhesion molecule-1, kidney integrity (kidney-specific proteins glutathione transferase-alpha; neutrophil gelatinase-associated lipocalin) were studied after induction of anesthesia, 5 h after surgery, 1 and 2 days thereafter. Serum creatinine (sCr) was measured approximately 60 days after discharge.

Results

A total of 2,750 ± 640 mL of balanced and 2,820 ± 550 mL of unbalanced HES were given until the second POD. Base excess (BE) was significantly reduced in the unbalanced (from +1.21 ± 0.3 to −4.39 ± 1.0 mmol L−1 5 h after surgery; P < 0.001) and remained unchanged in the balanced group (from 1.04 ± 0.3 to −0.81 ± 0.3 mmol L−1 5 h after surgery). Evolution of the BE was significantly different. Inflammatory response and endothelial activation were significantly less pronounced in the balanced than the unbalanced group. Concentrations of kidney-specific proteins after surgery indicated less alterations of kidney integrity in the balanced than in the unbalanced group.

Conclusions

A total balanced volume replacement strategy including a balanced HES and a balanced crystalloid solution resulted in moderate beneficial effects on acid-base status, inflammation, endothelial activation, and kidney integrity compared to a conventional unbalanced volume replacement regimen.
Literatur
1.
Zurück zum Zitat Hill GE (1998) Cardiopulmonary bypass-induced inflammation: is it important? J Cardiothorac Vasc Anesth 12(Suppl):S21–S25 Hill GE (1998) Cardiopulmonary bypass-induced inflammation: is it important? J Cardiothorac Vasc Anesth 12(Suppl):S21–S25
2.
Zurück zum Zitat Mythen MG, Salmon JB, Webb AR (1993) The rational administration of colloids. Blood Rev 7:223–228PubMedCrossRef Mythen MG, Salmon JB, Webb AR (1993) The rational administration of colloids. Blood Rev 7:223–228PubMedCrossRef
3.
Zurück zum Zitat Cussak RJ, Ball JAS, Rhdes A, Grounds RM (2002) Improving postoperative morbidity and mortality. Intensiv Med 39:571–577CrossRef Cussak RJ, Ball JAS, Rhdes A, Grounds RM (2002) Improving postoperative morbidity and mortality. Intensiv Med 39:571–577CrossRef
4.
Zurück zum Zitat Lacy JH, Wright CB (1992) Use of plasma volume expanders in myocardial revascularisation. Drugs 44:720–727PubMedCrossRef Lacy JH, Wright CB (1992) Use of plasma volume expanders in myocardial revascularisation. Drugs 44:720–727PubMedCrossRef
5.
Zurück zum Zitat Boldt J (2007) Pro: use of colloids in cardiac surgery. J Cardiothorac Vasc Anesth 21:453–456PubMedCrossRef Boldt J (2007) Pro: use of colloids in cardiac surgery. J Cardiothorac Vasc Anesth 21:453–456PubMedCrossRef
6.
Zurück zum Zitat Nuttall GA, Oliver WC (2007) Con: use of colloids in cardiac surgery. J Cardiothorac Vasc Anesth 21:453–456CrossRef Nuttall GA, Oliver WC (2007) Con: use of colloids in cardiac surgery. J Cardiothorac Vasc Anesth 21:453–456CrossRef
7.
Zurück zum Zitat Zander R (2006) Infusion fluids: why should they be balanced solution? EJHP Pract 12:1–4 Zander R (2006) Infusion fluids: why should they be balanced solution? EJHP Pract 12:1–4
8.
Zurück zum Zitat Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG (1999) Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesth Analg 88:992–998PubMed Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG (1999) Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesth Analg 88:992–998PubMed
9.
Zurück zum Zitat Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG (2001) The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93:811–816PubMedCrossRef Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG (2001) The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93:811–816PubMedCrossRef
10.
Zurück zum Zitat Wilkes NJ, Woolf RL, Powanda MC, Gan TJ, Machin SJ, Webb A, Mutch M, Bennett-Guerrero E, Mythen M (2002) Hydroxyethyl starch in balanced electrolyt solution (Hextend®)—pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesth Analg 94:538–544PubMedCrossRef Wilkes NJ, Woolf RL, Powanda MC, Gan TJ, Machin SJ, Webb A, Mutch M, Bennett-Guerrero E, Mythen M (2002) Hydroxyethyl starch in balanced electrolyt solution (Hextend®)—pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesth Analg 94:538–544PubMedCrossRef
11.
Zurück zum Zitat Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103:654–660PubMedCrossRef Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103:654–660PubMedCrossRef
12.
Zurück zum Zitat Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44:681–699PubMedCrossRef Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44:681–699PubMedCrossRef
13.
Zurück zum Zitat Boldt J Schöllhorn T, Schulte G, Pabsdorf M (2006) Volume replacement with a new balanced hydroxyethylstarch preparation (HES 130/0.42) in patients undergoing major abdominal surgery. EJA 231–239 Boldt J Schöllhorn T, Schulte G, Pabsdorf M (2006) Volume replacement with a new balanced hydroxyethylstarch preparation (HES 130/0.42) in patients undergoing major abdominal surgery. EJA 231–239
14.
Zurück zum Zitat Haynes GH, Havidich JE, Payne KJ (2004) Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101:560–561PubMedCrossRef Haynes GH, Havidich JE, Payne KJ (2004) Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101:560–561PubMedCrossRef
15.
Zurück zum Zitat Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA (2001) The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 92:1402–1407PubMedCrossRef Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA (2001) The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 92:1402–1407PubMedCrossRef
16.
Zurück zum Zitat Waitzinger J, Bepperling F, Pabst G, Opitz J (1998) Pharmacokinetics and tolerability of a new hydroxyethylstarch (HES) specification (HES 130/0.4) after single-dose infusion of 6% or 10% solution in healthy volunteers. Clin Drug Invest 16:151–160CrossRef Waitzinger J, Bepperling F, Pabst G, Opitz J (1998) Pharmacokinetics and tolerability of a new hydroxyethylstarch (HES) specification (HES 130/0.4) after single-dose infusion of 6% or 10% solution in healthy volunteers. Clin Drug Invest 16:151–160CrossRef
17.
Zurück zum Zitat L Rink, I Cakman, Kirchner H (1998) Altered cytokine production in the elderly. Mech Aging Dev 102:199–209CrossRef L Rink, I Cakman, Kirchner H (1998) Altered cytokine production in the elderly. Mech Aging Dev 102:199–209CrossRef
18.
Zurück zum Zitat Zaidi AM, Fitzpatrick AP, Keenan DJ, Odom NJ, Grotte GJ (1999) Good outcomes from cardiac surgery in the over 70s. Heart 82:134–137PubMed Zaidi AM, Fitzpatrick AP, Keenan DJ, Odom NJ, Grotte GJ (1999) Good outcomes from cardiac surgery in the over 70s. Heart 82:134–137PubMed
19.
Zurück zum Zitat Kellum JA (2002) Saline-induced hyperchloremic metabolic acidosis. Crit Care Med 30:259–261PubMedCrossRef Kellum JA (2002) Saline-induced hyperchloremic metabolic acidosis. Crit Care Med 30:259–261PubMedCrossRef
20.
Zurück zum Zitat Base E, Standl T, Mahl C, Jungheinrich C (2006) Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery. Crit Care 10(Suppl 1):P176CrossRef Base E, Standl T, Mahl C, Jungheinrich C (2006) Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery. Crit Care 10(Suppl 1):P176CrossRef
21.
Zurück zum Zitat Conlon PJ, Stafford-Smith M, White WD, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158–1162PubMedCrossRef Conlon PJ, Stafford-Smith M, White WD, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158–1162PubMedCrossRef
22.
Zurück zum Zitat Mills GH (2007) Hydroxyethyl starch: does our choice of colloid prevent or add renal impairment? Br J Anaesth 98:157–159PubMedCrossRef Mills GH (2007) Hydroxyethyl starch: does our choice of colloid prevent or add renal impairment? Br J Anaesth 98:157–159PubMedCrossRef
23.
Zurück zum Zitat Wiedermann CJ (2004) Hydroxyethyl starch—can the safety problems be ignored? Wien Klin Wochenschr 116:583–594PubMedCrossRef Wiedermann CJ (2004) Hydroxyethyl starch—can the safety problems be ignored? Wien Klin Wochenschr 116:583–594PubMedCrossRef
24.
Zurück zum Zitat Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249PubMedCrossRef Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249PubMedCrossRef
25.
Zurück zum Zitat Winkelmayer WC, Glynn RJ, Levin R, Avorn J (2003) Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64:1046–1049PubMedCrossRef Winkelmayer WC, Glynn RJ, Levin R, Avorn J (2003) Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64:1046–1049PubMedCrossRef
26.
Zurück zum Zitat Brunkhorst FM, Engel C, Bloos F, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRef Brunkhorst FM, Engel C, Bloos F, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRef
27.
Zurück zum Zitat Quilley CP, Lin YS, McGiff JC (1993) Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol 108:106–110PubMed Quilley CP, Lin YS, McGiff JC (1993) Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol 108:106–110PubMed
28.
Zurück zum Zitat Wilcox CS (1983) Regulation of renal blood flow by plasma chloride. J Clin Invest 71:726–735PubMedCrossRef Wilcox CS (1983) Regulation of renal blood flow by plasma chloride. J Clin Invest 71:726–735PubMedCrossRef
29.
Zurück zum Zitat Kotchen TA, Luke RG, Ott CE, Galla JH, Whitescarver S (1983) Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med 98:817–822PubMed Kotchen TA, Luke RG, Ott CE, Galla JH, Whitescarver S (1983) Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med 98:817–822PubMed
30.
Zurück zum Zitat Han WK, Bonventre JV (2004) Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 10:476–482PubMedCrossRef Han WK, Bonventre JV (2004) Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 10:476–482PubMedCrossRef
31.
Zurück zum Zitat Mishra J, Ma Q, Prada A, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 14:2534–2543PubMedCrossRef Mishra J, Ma Q, Prada A, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 14:2534–2543PubMedCrossRef
32.
Zurück zum Zitat Kellum JA, Song M, Almasri E (2006) Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130:962–967PubMedCrossRef Kellum JA, Song M, Almasri E (2006) Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130:962–967PubMedCrossRef
33.
Zurück zum Zitat Finfer S, Bellomo R, Boyce N (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256PubMedCrossRef Finfer S, Bellomo R, Boyce N (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256PubMedCrossRef
34.
Zurück zum Zitat Roche AM, James MF, Bennett-Guerrero E, Mythen MG (2006) A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 102:1274–1279PubMedCrossRef Roche AM, James MF, Bennett-Guerrero E, Mythen MG (2006) A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 102:1274–1279PubMedCrossRef
35.
Zurück zum Zitat Leverve XM, Boon C, Hakim T, Anwar M, Siregar E, Mustafa I (2008) Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Med. doi:10.1007/s00134-008-1165-x Leverve XM, Boon C, Hakim T, Anwar M, Siregar E, Mustafa I (2008) Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Med. doi:10.​1007/​s00134-008-1165-x
Metadaten
Titel
RETRACTED ARTICLE: The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients
verfasst von
Joachim Boldt
Stephan Suttner
Christian Brosch
Andreas Lehmann
Kerstin Röhm
Andinet Mengistu
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2009
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1287-1

Weitere Artikel der Ausgabe 3/2009

Intensive Care Medicine 3/2009 Zur Ausgabe

Correspondence

Reply to Kaufman

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.